KRYS Cash & Equivalents
Krystal Biotech Inc · Cash & Equivalents
KRYS Cash & Equivalents
Latest reported$496.30Mperiod ending
KRYS FY Cash & Equivalents ($1.92M → $496.30M)
Annual Cash & Equivalents
High-resolution chart · PNG
KRYS cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 496,304,000 | |
| 344,865,000 | |
| 358,328,000 | |
| 161,900,000 | |
| 341,246,000 | |
| 268,269,000 | |
| 187,514,000 | |
| 103,670,000 | |
| 49,591,000 | |
| 1,923,000 |